Sucaldito Ma Sergia Fatima P, Panganiban Bea Regine C, Jimeno Cecilia A
Philippine General Hospital, University of the Philippines Manila.
Acta Med Philipp. 2023 Dec 18;57(12):66-72. doi: 10.47895/amp.vi0.5764. eCollection 2023.
Prolonged nasopharyngeal carriage of SARS-CoV-2 has been linked to prolonged hospital stay and delayed radiologic recovery. To determine if clinical risk factors are associated with prolonged nasopharyngeal carriage or longer hospital stay, we performed a descriptive analysis of 169 moderate to severe COVID-19 patients admitted at the Philippine General Hospital from March to June 2020.
Length of nasopharyngeal RT-PCR positivity and clinical demographic data were extracted from existing patient records. Chi-square test, Mann-Whitney U test, and regression analysis were performed to describe the association of clinical risk factors with prolonged nasopharyngeal carriage and length of hospital stay.
The median duration of carriage was 19 days (IQR 12.0-30.0 days). No comorbidities or inflammatory markers had a statistically significant association with prolonged nasopharyngeal carriage defined as >24 days of nasopharyngeal RT-PCR positivity. Characteristics associated with a statistically significant longer hospital stay included chronic kidney disease stages 3-5, severe disease, and use of empiric antibiotics on admission. Prolonged carriage >24 days, hsCRP, and D-dimer at admission, also had a statistically significant but weak correlation with length of stay.
Among patients with moderate disease, comorbidities and inflammatory markers were not associated with prolonged COVID-19 nasopharyngeal carriage. Prolonged nasopharyngeal carriage >24 days was associated with longer hospital stay, while D-dimer and hsCRP levels at admission, also had statistically significant but small effects on increasing the hospital length of stay.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的鼻咽部长期携带与住院时间延长和影像学恢复延迟有关。为了确定临床风险因素是否与鼻咽部长期携带或更长的住院时间相关,我们对2020年3月至6月在菲律宾总医院收治的169例中重度新型冠状病毒肺炎(COVID-19)患者进行了描述性分析。
从现有的患者记录中提取鼻咽部逆转录聚合酶链反应(RT-PCR)阳性持续时间和临床人口统计学数据。进行卡方检验、曼-惠特尼U检验和回归分析,以描述临床风险因素与鼻咽部长期携带和住院时间的关联。
携带的中位持续时间为19天(四分位间距12.0 - 30.0天)。没有合并症或炎症标志物与定义为鼻咽部RT-PCR阳性>24天的鼻咽部长期携带存在统计学显著关联。与住院时间在统计学上显著延长相关的特征包括慢性肾脏病3 - 5期、重症疾病以及入院时使用经验性抗生素。携带>24天、入院时的高敏C反应蛋白(hsCRP)和D-二聚体,也与住院时间存在统计学显著但较弱的相关性。
在中度疾病患者中,合并症和炎症标志物与COVID-19鼻咽部长期携带无关。鼻咽部长期携带>24天与住院时间延长相关,而入院时的D-二聚体和hsCRP水平对住院时间延长也有统计学显著但较小的影响。